Stefan Buck

884 total citations
30 papers, 445 citations indexed

About

Stefan Buck is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Stefan Buck has authored 30 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Stefan Buck's work include Cyclopropane Reaction Mechanisms (6 papers), Asymmetric Hydrogenation and Catalysis (5 papers) and Advanced Breast Cancer Therapies (4 papers). Stefan Buck is often cited by papers focused on Cyclopropane Reaction Mechanisms (6 papers), Asymmetric Hydrogenation and Catalysis (5 papers) and Advanced Breast Cancer Therapies (4 papers). Stefan Buck collaborates with scholars based in Germany, Switzerland and United States. Stefan Buck's co-authors include Gerhard Maas, Neva Caliskan, Redmond P. Smyth, Matthias M. Zimmer, José Baselga, Rowan Stringer, Cristina Saura, Nathalie Gobeau, Tove Tuntland and Guy Jérusalem and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Blood.

In The Last Decade

Stefan Buck

29 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Buck Germany 11 201 119 83 69 48 30 445
Lili Zhu China 14 211 1.0× 85 0.7× 70 0.8× 82 1.2× 36 0.8× 38 455
Zilun Hu United States 11 175 0.9× 144 1.2× 132 1.6× 35 0.5× 27 0.6× 23 460
Peyman Obeidy Australia 11 206 1.0× 186 1.6× 67 0.8× 51 0.7× 50 1.0× 19 607
Jim Nonomiya United States 13 390 1.9× 127 1.1× 127 1.5× 52 0.8× 63 1.3× 18 659
Chiara Rusconi Italy 15 123 0.6× 182 1.5× 78 0.9× 43 0.6× 82 1.7× 53 563
Roger Y. Tsang Canada 8 135 0.7× 154 1.3× 40 0.5× 41 0.6× 37 0.8× 21 399
Sadayappan V. Rahavendran United States 13 170 0.8× 74 0.6× 89 1.1× 86 1.2× 17 0.4× 18 506
Tanja Peters Germany 7 122 0.6× 92 0.8× 39 0.5× 96 1.4× 21 0.4× 11 490
Yanli Song China 13 204 1.0× 47 0.4× 57 0.7× 254 3.7× 38 0.8× 41 579
Oleg Brodsky United States 6 236 1.2× 104 0.9× 90 1.1× 65 0.9× 16 0.3× 7 438

Countries citing papers authored by Stefan Buck

Since Specialization
Citations

This map shows the geographic impact of Stefan Buck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Buck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Buck more than expected).

Fields of papers citing papers by Stefan Buck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Buck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Buck. The network helps show where Stefan Buck may publish in the future.

Co-authorship network of co-authors of Stefan Buck

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Buck. A scholar is included among the top collaborators of Stefan Buck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Buck. Stefan Buck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Buck, Stefan, Patrick Bohn, Andreas Schlösser, et al.. (2025). The translational landscape of HIV-1 infected cells reveals key gene regulatory principles. Nature Structural & Molecular Biology. 32(5). 841–852. 2 indexed citations
2.
Morganti, Simonetta, Melissa E. Hughes, Thomas Grinda, et al.. (2025). Survival outcomes and the role of DNADX ctDNA testing in patients treated with sacituzumab govitecan for metastatic breast cancer. ESMO Open. 10(10). 105828–105828.
3.
Graham, Noah, Melissa E. Hughes, Karen L. Smith, et al.. (2024). 213P Sequencing antibody-drug conjugates (ADCs) in patients (pts) with HER2-negative (HER2-) metastatic breast cancer (mBC). ESMO Open. 9. 103235–103235. 3 indexed citations
4.
Buck, Stefan, et al.. (2022). POTATO: Automated pipeline for batch analysis of optical tweezers data. Biophysical Journal. 121(15). 2830–2839. 5 indexed citations
5.
Buck, Stefan, et al.. (2022). Optical Tweezers to Study RNA-Protein Interactions in Translation Regulation. Journal of Visualized Experiments. 4 indexed citations
6.
7.
Zimmer, Matthias M., Ulfert Rand, Liqing Ye, et al.. (2021). The short isoform of the host antiviral protein ZAP acts as an inhibitor of SARS-CoV-2 programmed ribosomal frameshifting. Nature Communications. 12(1). 7193–7193. 62 indexed citations
8.
9.
Dörner, Thomas, Margit Zeher, Ute Laessing, et al.. (2018). OP0250 A randomised, double-blind study to assess the safety, tolerability and preliminary efficacy of leniolisib (CDZ173) in patients with primary sjÖgren's syndrome. Annals of the Rheumatic Diseases. 77. 174–174. 15 indexed citations
10.
Gobeau, Nathalie, et al.. (2016). Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery. Pharmaceutical Research. 33(9). 2126–2139. 44 indexed citations
11.
Saura, Cristina, Johanna C. Bendell, Guy Jérusalem, et al.. (2014). Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy. Clinical Cancer Research. 20(7). 1935–1945. 110 indexed citations
12.
Juric, Dejan, Martin Schüler, Jordan Berlin, et al.. (2013). Abstract P2-16-14: Preliminary safety, pharmacokinetics and anti-tumor activity of BYL719, an alpha-specific PI3K inhibitor in combination with fulvestrant: Results from a phase I study. Cancer Research. 73(24_Supplement). P2–16. 12 indexed citations
13.
Buck, Stefan, et al.. (2012). Intramolecular carbenoid ylide forming reactions of 2-diazo-3-keto-4-phthalimidocarboxylic esters derived from methionine and cysteine. Beilstein Journal of Organic Chemistry. 8. 433–440. 5 indexed citations
14.
Müller, Tobias, et al.. (2012). Ruthenium- and Rhodium-catalyzed Carbenoid Reactions of Diazoesters in Hexaalkylguanidinium-based Ionic Liquids. Zeitschrift für Naturforschung B. 67(4). 347–353. 4 indexed citations
15.
16.
17.
Saura, Cristina, Johanna C. Bendell, Guy Jérusalem, et al.. (2011). PD09-03: Phase I/II Study of BKM120 in Combination with Trastuzumab in Patients with HER2 Overexpressing Metastatic Breast Cancer Resistant to Trastuzumab-Containing Therapy.. Cancer Research. 71(24_Supplement). PD09–3. 4 indexed citations
18.
Buck, Stefan, et al.. (2007). 6-Halogenopyridin-2-olato complexes with the diruthenium(2+) core: Equilibria between head-to-head and head-to-tail structures. Inorganica Chimica Acta. 361(1). 109–122. 4 indexed citations
19.
Buck, Stefan & Gerhard Maas. (2006). Diruthenium(I,I) saccharinate complexes: Synthesis, molecular structure, and evaluation as catalysts for carbenoid reactions of diazoacetates. Journal of Organometallic Chemistry. 691(12). 2774–2784. 23 indexed citations
20.
Augustijns, Patrick, J. Van Gelder, Guy Van den Mooter, et al.. (2000). Oral absorption characteristics of the antiviral agent UC-781. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lili Zhu Breakdown of academic impact, for papers by Zilun Hu Breakdown of academic impact, for papers by Peyman Obeidy Breakdown of academic impact, for papers by Jim Nonomiya Breakdown of academic impact, for papers by Chiara Rusconi Breakdown of academic impact, for papers by Roger Y. Tsang Breakdown of academic impact, for papers by Sadayappan V. Rahavendran Breakdown of academic impact, for papers by Tanja Peters Breakdown of academic impact, for papers by Yanli Song Breakdown of academic impact, for papers by Oleg Brodsky
Rankless by CCL
2026